Division of Immunology & Pathogenesis, Department of Molecular & Cell Biology, and Cancer Research Laboratory, University of California, Berkeley, CA, USA.
Division of Immunology & Pathogenesis, Department of Molecular & Cell Biology, and Cancer Research Laboratory, University of California, Berkeley, CA, USA; Howard Hughes Medical Institute, University of California, Berkeley, CA, USA.
Curr Opin Immunol. 2019 Oct;60:37-45. doi: 10.1016/j.coi.2019.04.015. Epub 2019 May 20.
Nucleotide-binding domain, leucine-rich repeat (NLR) proteins constitute a diverse class of innate immune sensors that detect pathogens or stress-associated stimuli in plants and animals. Some NLRs are activated upon direct binding to pathogen-derived ligands. In contrast, we focus here on a vertebrate NLR called NLRP1 that responds to the enzymatic activities of pathogen effectors. We discuss a newly proposed 'functional degradation' mechanism that explains activation and assembly of NLRP1 into an oligomeric complex called an inflammasome. We also discuss how NLRP1 is activated by non-pathogen-associated triggers such as the anti-cancer drug Val-boroPro, or by human disease-associated mutations. Finally, we discuss how research on NLRP1 has led to additional biological insights, including the unexpected discovery of a new CARD8 inflammasome.
核苷酸结合域富含亮氨酸重复(NLR)蛋白构成了一类广泛的先天免疫传感器,可在动植物中检测病原体或与应激相关的刺激物。一些 NLR 通过直接结合病原体衍生的配体而被激活。相比之下,我们在此重点关注一种称为 NLRP1 的脊椎动物 NLR,它对病原体效应物的酶活性作出反应。我们讨论了一个新提出的“功能降解”机制,该机制解释了 NLRP1 如何激活并组装成一种称为炎性小体的寡聚复合物。我们还讨论了 NLRP1 如何被非病原体相关的触发物激活,如抗癌药物 Val-boroPro,或人类疾病相关的突变。最后,我们讨论了 NLRP1 的研究如何带来了其他生物学见解,包括对新的 CARD8 炎性小体的意外发现。